DMedical announced today that it raised more than $100 million (AU$150 million) through a new institutional placement.

Lung-imaging house 4D Medical is finalising its monster $150 million fund raising for a "once in a generation" US opportunity ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and ...

Following the raise, 4DMedical reported a pro forma cash position exceeding US$130+ million (AU$200+ million), which will ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...

These shares have made their shareholders wealthy over the past year. The post Why 4DMedical and these ASX shares are up ...

FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...

In 2025, New England Donor Services coordinated organ donations from 640 deceased donors resulting in a record 1,692 life-saving organ transplants ...

VQ lung imaging technology at the University of Chicago Medicine. This follows an expanded agreement that will see the technology integrated into clinical workflows within the Interventional ...

DMedical Limited (ASX:4DX), a global leader in respiratory imaging technology, has announced an expanded partnership with the ...

Let’s Innovate Together!’ During my tenure as ASNC president, I will work tirelessly so we can innovate together as the global community of nuclear cardiology professionals.” — Jamieson M. Bourque, MD ...

Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today announced the expansion of its Xenon MRI platform into cardiopulmonary pharma-sponsored drug ...